28 29 In Japan, support for PAD legalisation ranged from 56.3% to 74% in 2010, and the willingness to use PAD increased from 5% in 2008 to 18% in 2010, marking a clear trend towards acceptance of PAD as a secondary choice for end-of-life decisions. 30 31 The launch of Taiwan’s Patient Right to Autonomy Act (PRAA) in 2019, recognising the right to decline life-sustaining treatments in scenario of terminal illness, comatose state, severe cognitive impairment and other conditions of non-terminal intractable suffering, marks a significant advancement in end-of-life care management.
← all excerpts
Cross-sectional survey on public attitudes and factors related to physician-assisted dying in Taiwan.
1
—
—